Natalia Shcherbakova Ph.D., Kimberly Pesaturo Pharm.D., John M. Pezzuto Ph.D., D.Sc.
{"title":"Comment on “Falling pass rates on the North American Pharmacist Licensure Examination signal an emerging crisis for a growing number of pharmacy schools”","authors":"Natalia Shcherbakova Ph.D., Kimberly Pesaturo Pharm.D., John M. Pezzuto Ph.D., D.Sc.","doi":"10.1002/jac5.2036","DOIUrl":"https://doi.org/10.1002/jac5.2036","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 11","pages":"1133"},"PeriodicalIF":1.3,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142665990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Response to Comment on “Falling pass rates on the North American Pharmacist Licensure Examination signal an emerging crisis for a growing number of pharmacy schools”","authors":"Daniel L. Brown Pharm.D.","doi":"10.1002/jac5.2037","DOIUrl":"https://doi.org/10.1002/jac5.2037","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 11","pages":"1134"},"PeriodicalIF":1.3,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142665735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pharmacists should be held to high standards, not hindered by bright-line rules","authors":"Stuart T. Haines Pharm.D., FCCP","doi":"10.1002/jac5.2038","DOIUrl":"https://doi.org/10.1002/jac5.2038","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 11","pages":"1074-1076"},"PeriodicalIF":1.3,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142665988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Celeste Noelle Bustria B.S., Finan Yohannes, Jennifer Cocohoba Pharm.D., MAS, Lee Nguyen Pharm.D., Nimish Patel Pharm.D., Ph.D., Parya Saberi Pharm.D., MAS
Introduction
Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) significantly reduces the risk of acquiring HIV. To increase PrEP prescribing, it is crucial to evaluate the preparedness of future pharmacists who will play a pivotal role in providing PrEP education, counseling, and prescribing.
Objective
We assessed PrEP-prescribing knowledge, attitudes, and HIV-related stigma of pharmacy students.
Methods
We conducted a cross-sectional web-based survey of student pharmacists in their final two years of education and training at the three University of California pharmacy schools. Survey questions assessed students' awareness of PrEP, familiarity with prescribing guidelines and Senate Bill 159 (SB159), PrEP knowledge, HIV-related stigma, and attitudes about PrEP. The sample was characterized using descriptive statistics, and non-parametric tests were used to examine associations between dependent variables and independent variables. A p-value <0.05 was deemed statistically significant.
Results
A total of 110 students participated in the survey. The greatest familiarity with guidelines was observed in male (77.4%) (p = 0.047) and gay-identifying (100%) (p = 0.039) students compared with other genders and sexual identities, respectively. Non-advanced pharmacy practice experience (APPE) students (70.3%) displayed significantly more familiarity with SB159 than APPE students (65.2%) (p = 0.006). Non-APPE students displayed higher HIV-related stigma compared with APPE students (13.8 vs. 9.4, p = 0.0015). Significant differences in PrEP knowledge (p = 0.0105), HIV-related stigma (p = 0.0003), and PrEP attitudes (p = 0.0098) were observed between the schools. African American students had a significantly higher mean PrEP attitudes score (mean = 51.0, standard deviation [SD] = 3.6) compared with other racial categories (p = 0.0329).
Conclusion
Elevated HIV-related stigma, in the presence of high levels of PrEP knowledge, highlights the need to focus on destigmatizing HIV prevention services and increasing anti-stigma training, which is imperative in preparing student pharmacists to prescribe PrEP.
{"title":"Assessing pharmacy students' HIV pre-exposure prophylaxis (PrEP) prescribing knowledge, PrEP attitudes, and HIV-related stigma","authors":"Celeste Noelle Bustria B.S., Finan Yohannes, Jennifer Cocohoba Pharm.D., MAS, Lee Nguyen Pharm.D., Nimish Patel Pharm.D., Ph.D., Parya Saberi Pharm.D., MAS","doi":"10.1002/jac5.2043","DOIUrl":"https://doi.org/10.1002/jac5.2043","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) significantly reduces the risk of acquiring HIV. To increase PrEP prescribing, it is crucial to evaluate the preparedness of future pharmacists who will play a pivotal role in providing PrEP education, counseling, and prescribing.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>We assessed PrEP-prescribing knowledge, attitudes, and HIV-related stigma of pharmacy students.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a cross-sectional web-based survey of student pharmacists in their final two years of education and training at the three University of California pharmacy schools. Survey questions assessed students' awareness of PrEP, familiarity with prescribing guidelines and Senate Bill 159 (SB159), PrEP knowledge, HIV-related stigma, and attitudes about PrEP. The sample was characterized using descriptive statistics, and non-parametric tests were used to examine associations between dependent variables and independent variables. A p-value <0.05 was deemed statistically significant.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 110 students participated in the survey. The greatest familiarity with guidelines was observed in male (77.4%) (<i>p</i> = 0.047) and gay-identifying (100%) (<i>p</i> = 0.039) students compared with other genders and sexual identities, respectively. Non-advanced pharmacy practice experience (APPE) students (70.3%) displayed significantly more familiarity with SB159 than APPE students (65.2%) (<i>p</i> = 0.006). Non-APPE students displayed higher HIV-related stigma compared with APPE students (13.8 vs. 9.4, <i>p</i> = 0.0015). Significant differences in PrEP knowledge (<i>p</i> = 0.0105), HIV-related stigma (<i>p</i> = 0.0003), and PrEP attitudes (<i>p</i> = 0.0098) were observed between the schools. African American students had a significantly higher mean PrEP attitudes score (mean = 51.0, standard deviation [SD] = 3.6) compared with other racial categories (<i>p</i> = 0.0329).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Elevated HIV-related stigma, in the presence of high levels of PrEP knowledge, highlights the need to focus on destigmatizing HIV prevention services and increasing anti-stigma training, which is imperative in preparing student pharmacists to prescribe PrEP.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 11","pages":"1107-1113"},"PeriodicalIF":1.3,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.2043","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142665789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amy L. Ives Pharm.D., Marina L. Maes Pharm.D., Kathryn Sawyer Pharm.D., MBA, Jessica M. Bergbaken Pharm.D., Jared Van Hooser Pharm.D., Michelle Fravel Pharm.D., FCCP, Kristen Cook Pharm.D.
Introduction
Competent navigation of an electronic health record (EHR) has become a critical skill for health professionals, and pharmacists need to be adept in EHR utilization given the extent of EHR involvement in routine medication management. Limited data exists related to current approaches to teaching EHR skills in pre-Advanced Pharmacy Practice Experiences (pre-APPE) pharmacy curricula.
Objectives
The purpose of this study was to describe activities, utilization, and barriers to implementation of teaching EHRs (tEHRs) into pharmacy curricula in skills-based courses.
Methods
Faculty members of the Big Ten Academic Alliance Skills-Based Education and Assessment Collaborative (BTAA-SBEAC) were surveyed. The questionnaire included open-ended questions related to tEHR type, curriculum placement, and current use of tEHRs, as well as barriers to incorporation of tEHRs in the curriculum. Inductive content analysis was used to evaluate qualitative responses.
Results
A representative from all 10 colleges within the BTAA responded. Most programs focused on EHR teaching in the second and third years of the curriculum. All respondents reported having access to a tEHR for internal case building. The tEHR was used by all institutions to allow students to practice in gathering patient information as the first step in the Pharmacists' Patient Care Process. Other activities commonly performed using the tEHR included patient care documentation, medication order verification, prescription processing, and medication reconciliation. Faculty time and cost were barriers identified for successful tEHR implementation.
Conclusion
Multiple skills are taught through the utilization of a tEHR among the colleges within the BTAA. These activities vary between institutions, and barriers exist that limit expansion and consistent integration across a skills-based curriculum. Recognition of EHR utilization as an essential pharmacy skill can allow for development of formalized learning outcomes, leading to better support and integration throughout skills-based courses.
{"title":"Charting a course: Use of Electronic Health Records in skills-based pharmacy education","authors":"Amy L. Ives Pharm.D., Marina L. Maes Pharm.D., Kathryn Sawyer Pharm.D., MBA, Jessica M. Bergbaken Pharm.D., Jared Van Hooser Pharm.D., Michelle Fravel Pharm.D., FCCP, Kristen Cook Pharm.D.","doi":"10.1002/jac5.2042","DOIUrl":"https://doi.org/10.1002/jac5.2042","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Competent navigation of an electronic health record (EHR) has become a critical skill for health professionals, and pharmacists need to be adept in EHR utilization given the extent of EHR involvement in routine medication management. Limited data exists related to current approaches to teaching EHR skills in pre-Advanced Pharmacy Practice Experiences (pre-APPE) pharmacy curricula.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The purpose of this study was to describe activities, utilization, and barriers to implementation of teaching EHRs (tEHRs) into pharmacy curricula in skills-based courses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Faculty members of the Big Ten Academic Alliance Skills-Based Education and Assessment Collaborative (BTAA-SBEAC) were surveyed. The questionnaire included open-ended questions related to tEHR type, curriculum placement, and current use of tEHRs, as well as barriers to incorporation of tEHRs in the curriculum. Inductive content analysis was used to evaluate qualitative responses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A representative from all 10 colleges within the BTAA responded. Most programs focused on EHR teaching in the second and third years of the curriculum. All respondents reported having access to a tEHR for internal case building. The tEHR was used by all institutions to allow students to practice in gathering patient information as the first step in the Pharmacists' Patient Care Process. Other activities commonly performed using the tEHR included patient care documentation, medication order verification, prescription processing, and medication reconciliation. Faculty time and cost were barriers identified for successful tEHR implementation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Multiple skills are taught through the utilization of a tEHR among the colleges within the BTAA. These activities vary between institutions, and barriers exist that limit expansion and consistent integration across a skills-based curriculum. Recognition of EHR utilization as an essential pharmacy skill can allow for development of formalized learning outcomes, leading to better support and integration throughout skills-based courses.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 11","pages":"1099-1106"},"PeriodicalIF":1.3,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.2042","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142665925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Christy Forehand Pharm.D., Russel Roberts Pharm.D., Nicole M. Acquisto Pharm.D., FCCP, Mitchell Buckley Pharm.D., FCCP, Christine M. Groth Pharm.D., Devin Holden Pharm.D., Andrea Sikora Pharm.D., Thomas (Tomi) Ardiles M.D., Melissa Thompson Bastin Pharm.D., Ph.D., Sivasubramanium V. Bhavani M.D., Ashley DePriest M.S., Ifeoma Mary Eche Pharm.D., Brigid Flynn M.D., William J. Healy M.D., Brett Hogan MSN, Brenton LaRiccia M.S., MBA, Kirby Mayer DPT, Ph.D., David Murphy M.D., Ph.D., Lucy Stun Pharm.D., Shan Wang Pharm.D., Nicola Zetola M.D., Robert MacLaren Pharm.D., MPH, FCCP
Background
Critical care pharmacists are well-established, valuable members of the intensive care unit interprofessional team with unique skills to perform comprehensive medication management in complex critically ill patients. However, standardized and consequential productivity metrics for critical care pharmacists have not been established.
Objective
To characterize the utilization and perception of contemporary critical care pharmacy productivity metrics utilized among individual institutions.
Design, Setting, and Participants
An electronic survey was distributed to critical care pharmacist members of the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology Section and the American College of Clinical Pharmacy Critical Care Practice and Research Network.
Main Outcomes and Measures
The survey included 23 questions to assess institution demographics, individual respondent demographics, institution practices, and individual respondent perceptions about the value of critical care pharmacist productivity metrics.
Results
A total of 204 critical care pharmacists, largely from the United States, responded to the survey between July and November 2022. Institutional metrics captured by more than 50% of the respondents' institutions included order verification rate/number of orders verified (60%), number of clinical interventions (57%), and intravenous to enteral product interchanges (52%). Of these metrics, critical care pharmacists only agreed with the value of the number of clinical interventions, were indifferent to the value of intravenous to oral product interchanges, and disagreed with the value of order verification rate/number of orders verified.
Conclusions
Significant discrepancies exist between institutional productivity metric practices and their perceived value and utility among critical care pharmacists.
{"title":"EXaminaTion of cRitical cAre PHArmacist pRoductivity MetricS (EXTRA-PHARMS): The clinical pharmacist's perspective","authors":"Christy Forehand Pharm.D., Russel Roberts Pharm.D., Nicole M. Acquisto Pharm.D., FCCP, Mitchell Buckley Pharm.D., FCCP, Christine M. Groth Pharm.D., Devin Holden Pharm.D., Andrea Sikora Pharm.D., Thomas (Tomi) Ardiles M.D., Melissa Thompson Bastin Pharm.D., Ph.D., Sivasubramanium V. Bhavani M.D., Ashley DePriest M.S., Ifeoma Mary Eche Pharm.D., Brigid Flynn M.D., William J. Healy M.D., Brett Hogan MSN, Brenton LaRiccia M.S., MBA, Kirby Mayer DPT, Ph.D., David Murphy M.D., Ph.D., Lucy Stun Pharm.D., Shan Wang Pharm.D., Nicola Zetola M.D., Robert MacLaren Pharm.D., MPH, FCCP","doi":"10.1002/jac5.2040","DOIUrl":"https://doi.org/10.1002/jac5.2040","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Critical care pharmacists are well-established, valuable members of the intensive care unit interprofessional team with unique skills to perform comprehensive medication management in complex critically ill patients. However, standardized and consequential productivity metrics for critical care pharmacists have not been established.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To characterize the utilization and perception of contemporary critical care pharmacy productivity metrics utilized among individual institutions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design, Setting, and Participants</h3>\u0000 \u0000 <p>An electronic survey was distributed to critical care pharmacist members of the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology Section and the American College of Clinical Pharmacy Critical Care Practice and Research Network.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Outcomes and Measures</h3>\u0000 \u0000 <p>The survey included 23 questions to assess institution demographics, individual respondent demographics, institution practices, and individual respondent perceptions about the value of critical care pharmacist productivity metrics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 204 critical care pharmacists, largely from the United States, responded to the survey between July and November 2022. Institutional metrics captured by more than 50% of the respondents' institutions included order verification rate/number of orders verified (60%), number of clinical interventions (57%), and intravenous to enteral product interchanges (52%). Of these metrics, critical care pharmacists only agreed with the value of the number of clinical interventions, were indifferent to the value of intravenous to oral product interchanges, and disagreed with the value of order verification rate/number of orders verified.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Significant discrepancies exist between institutional productivity metric practices and their perceived value and utility among critical care pharmacists.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 11","pages":"1084-1093"},"PeriodicalIF":1.3,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Susan E. Smith Pharm.D., Christopher M. Bland Pharm.D., FCCP, Trisha N. Branan Pharm.D., Andrea Sikora Pharm.D., MSCR, FCCP, William Anthony Hawkins Pharm.D.
The pursuit of research and scholarly productivity is critical for clinician scientists, yet achieving impactful outcomes often necessitates collaboration within a well-structured team. This review explores the foundational elements of team building that support sustained research productivity among health care professionals and academicians. Drawing on principles from team science, the importance of establishing a shared vision and mission, fostering authentic relationships, and creating an efficient infrastructure to enhance and sustain collaborative efforts is discussed. The four stages of team development—forming, storming, norming, and performing—are examined to provide insights into the dynamic nature of teamwork. Emphasizing the need for intentional practices, we highlight methods for identifying and integrating team members, managing conflicts, and leveraging diverse skill sets to achieve collective goals. Best practices for sustaining research teams, including the implementation of SMART (Specific, Measurable, Assignable, Realistic, Time-related) goals, regular retreats, and strategic alignment of activities to maximize output are also discussed. Two collaborative teams are used as exemplars to illustrate the successful application of these principles, resulting in significant scholarly output. By understanding and applying the concepts of team building, clinician scientists can enhance their research output, contribute to the advancement of health care, and achieve a fulfilling and sustainable career.
{"title":"Research and scholarly methods: Research collaboration","authors":"Susan E. Smith Pharm.D., Christopher M. Bland Pharm.D., FCCP, Trisha N. Branan Pharm.D., Andrea Sikora Pharm.D., MSCR, FCCP, William Anthony Hawkins Pharm.D.","doi":"10.1002/jac5.2041","DOIUrl":"https://doi.org/10.1002/jac5.2041","url":null,"abstract":"<p>The pursuit of research and scholarly productivity is critical for clinician scientists, yet achieving impactful outcomes often necessitates collaboration within a well-structured team. This review explores the foundational elements of team building that support sustained research productivity among health care professionals and academicians. Drawing on principles from team science, the importance of establishing a shared vision and mission, fostering authentic relationships, and creating an efficient infrastructure to enhance and sustain collaborative efforts is discussed. The four stages of team development—forming, storming, norming, and performing—are examined to provide insights into the dynamic nature of teamwork. Emphasizing the need for intentional practices, we highlight methods for identifying and integrating team members, managing conflicts, and leveraging diverse skill sets to achieve collective goals. Best practices for sustaining research teams, including the implementation of SMART (Specific, Measurable, Assignable, Realistic, Time-related) goals, regular retreats, and strategic alignment of activities to maximize output are also discussed. Two collaborative teams are used as exemplars to illustrate the successful application of these principles, resulting in significant scholarly output. By understanding and applying the concepts of team building, clinician scientists can enhance their research output, contribute to the advancement of health care, and achieve a fulfilling and sustainable career.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 11","pages":"1122-1132"},"PeriodicalIF":1.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.2041","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stamm PL, Haines ST, Edwards KL, Fusco NM, Havrda DE, Lee KC, et al. Educational outcomes necessary to enter pharmacy residency training: 2023 update. J Am Coll Clin Pharm. 2024;7(9):952–6. https://doi.org/10.1002/jac5.1994
The American College of Clinical Pharmacy (ACCP) Board of Regents approval date was excluded from the original publication. This Position Statement was approved by the ACCP Board of Regents on November 9, 2023.
{"title":"Correction to “Educational outcomes necessary to enter pharmacy residency training: 2023 update”","authors":"","doi":"10.1002/jac5.2039","DOIUrl":"https://doi.org/10.1002/jac5.2039","url":null,"abstract":"<p>Stamm PL, Haines ST, Edwards KL, Fusco NM, Havrda DE, Lee KC, et al. Educational outcomes necessary to enter pharmacy residency training: 2023 update. J Am Coll Clin Pharm. 2024;7(9):952–6. https://doi.org/10.1002/jac5.1994</p><p>The American College of Clinical Pharmacy (ACCP) Board of Regents approval date was excluded from the original publication. This Position Statement was approved by the ACCP Board of Regents on November 9, 2023.</p><p>We apologize for this error.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 11","pages":"1139"},"PeriodicalIF":1.3,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.2039","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kelli Boyden JD, Randy C. Hatton Pharm.D., FCCP, Catherine M. Lynch M.D., David B. Brushwood BSPharm, JD
This analysis explores the basis for the US Food and Drug Administration (FDA) requiring a Risk Evaluation and Mitigation Strategy (REMS) for mifepristone for the termination of intrauterine pregnancy. Controversies surround mifepristone and its REMS. The safety and efficacy of mifepristone are briefly reviewed with respect to FDA's actions. It is difficult to justify the continued requirement for a REMS for mifepristone by applying the regulatory framework and considering mifepristone's safety record. Drugs with higher risks are on the US market without an FDA-mandated REMS. Canada removed all restrictions on the use of mifepristone for abortion, which has not resulted in patient safety concerns. All pharmacists should be permitted to dispense mifepristone. The continued requirement for a mifepristone REMS in the US appears to be based more on politics rather than evidence.
本分析探讨了美国食品和药物管理局（FDA）要求米非司酮用于终止宫内妊娠的风险评估和缓解策略（REMS）的依据。围绕米非司酮及其 REMS 存在争议。本文就 FDA 的行动简要回顾了米非司酮的安全性和有效性。通过应用监管框架和考虑米非司酮的安全记录，很难证明继续要求米非司酮实施 REMS 是合理的。美国市场上有风险更高的药物，但没有食品与药物管理局规定的 REMS。加拿大取消了对使用米非司酮进行人工流产的所有限制，这并未导致对患者安全的担忧。应允许所有药剂师配发米非司酮。美国对米非司酮 REMS 的持续要求似乎更多是基于政治而非证据。
{"title":"Restrictions on pharmacist dispensing of mifepristone remain a hard pill to swallow","authors":"Kelli Boyden JD, Randy C. Hatton Pharm.D., FCCP, Catherine M. Lynch M.D., David B. Brushwood BSPharm, JD","doi":"10.1002/jac5.2034","DOIUrl":"https://doi.org/10.1002/jac5.2034","url":null,"abstract":"<p>This analysis explores the basis for the US Food and Drug Administration (FDA) requiring a Risk Evaluation and Mitigation Strategy (REMS) for mifepristone for the termination of intrauterine pregnancy. Controversies surround mifepristone and its REMS. The safety and efficacy of mifepristone are briefly reviewed with respect to FDA's actions. It is difficult to justify the continued requirement for a REMS for mifepristone by applying the regulatory framework and considering mifepristone's safety record. Drugs with higher risks are on the US market without an FDA-mandated REMS. Canada removed all restrictions on the use of mifepristone for abortion, which has not resulted in patient safety concerns. All pharmacists should be permitted to dispense mifepristone. The continued requirement for a mifepristone REMS in the US appears to be based more on politics rather than evidence.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 11","pages":"1114-1121"},"PeriodicalIF":1.3,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jerica Singleton Pharm.D., Gwendolyn A. Wantuch Pharm.D.
Introduction
The prevalence of overweight and obesity is increasing in America, contributing to various health risks. Glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP) receptor agonists have bloomed in popularity due to their efficacy and United States Food and Drug Administration (FDA) approval for weight loss, igniting popularity on social media. This study focuses on the role of TikTok™ (ByteDance, Haidian, Beijing, China), a popular social media platform, in disseminating understandable and actionable information about the side effects of weight loss medications.
Methods
The study analyzed the top 50 TikTok videos for each of the following hashtags: #ozempicsideeffects, #semaglutidesideeffects, #mounjarosideeffects, and #wegovysideeffects. Videos were evaluated based on their understandability and actionability using the Patient Education Materials Assessment Tool (PEMAT) for audio-visual (AV) products. PEMAT-AV scores and popularity of videos were compared between hashtags utilizing one-way analysis of variance (ANOVA). An alpha of 0.05 was used, with Bonferroni correction.
Results
A total of 165 videos were reviewed for PEMAT-AV understandability and actionability scores. The total visibility of the videos reached over 19.4 million views. A majority of the videos were personal experiences (89%), with only 5% being health care education videos. The average understandability and actionability scores for all videos were 43% and 20%, respectfully. The data presented a difference between searched hashtags for both evaluation scores, p-values of <0.001 and 0.093, respectively.
Conclusion
TikTok videos covering weight loss medication side effects have poor understandability and actionability scores. This study highlights the opportunity for more educational videos produced by health care professionals on TikTok, and a potential need for health care organizations and/or colleges of pharmacy to provide education to health care providers on how to create quality content for medication education on social media-based platforms. Further research is needed to evaluate the credibility of content.
{"title":"Evaluation of TikTok social media posts on side effect information for popular weight loss medications","authors":"Jerica Singleton Pharm.D., Gwendolyn A. Wantuch Pharm.D.","doi":"10.1002/jac5.2035","DOIUrl":"https://doi.org/10.1002/jac5.2035","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The prevalence of overweight and obesity is increasing in America, contributing to various health risks. Glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP) receptor agonists have bloomed in popularity due to their efficacy and United States Food and Drug Administration (FDA) approval for weight loss, igniting popularity on social media. This study focuses on the role of TikTok™ (ByteDance, Haidian, Beijing, China), a popular social media platform, in disseminating understandable and actionable information about the side effects of weight loss medications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The study analyzed the top 50 TikTok videos for each of the following hashtags: #ozempicsideeffects, #semaglutidesideeffects, #mounjarosideeffects, and #wegovysideeffects. Videos were evaluated based on their understandability and actionability using the Patient Education Materials Assessment Tool (PEMAT) for audio-visual (AV) products. PEMAT-AV scores and popularity of videos were compared between hashtags utilizing one-way analysis of variance (ANOVA). An alpha of 0.05 was used, with Bonferroni correction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 165 videos were reviewed for PEMAT-AV understandability and actionability scores. The total visibility of the videos reached over 19.4 million views. A majority of the videos were personal experiences (89%), with only 5% being health care education videos. The average understandability and actionability scores for all videos were 43% and 20%, respectfully. The data presented a difference between searched hashtags for both evaluation scores, <i>p</i>-values of <0.001 and 0.093, respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>TikTok videos covering weight loss medication side effects have poor understandability and actionability scores. This study highlights the opportunity for more educational videos produced by health care professionals on TikTok, and a potential need for health care organizations and/or colleges of pharmacy to provide education to health care providers on how to create quality content for medication education on social media-based platforms. Further research is needed to evaluate the credibility of content.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 11","pages":"1077-1083"},"PeriodicalIF":1.3,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142665939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号